View
1
Download
0
Category
Preview:
Citation preview
~~ Natraj Proteins Limited SOLVENT EXTRACTION PLANT & REFINERY Nagpur Kalan, Ordinance Factory Road, ITARSI
Ph.No. 07572- 262637, 262640, Fax No. 07572-262639
Ref. :
Email : natrajproteinitd@rediffmail.com be CIN : L00153 MP 1990 PLC 006090 Natraj
Date :
NPL/SE/2021 10" Feb., 2021
online filing at www.listing.bseindia.com To,
The General Manager DCS-CRD
BSE Ltd.
Phiroze Jeejeebhoy Towers Dalal Street, Fort
MUMBAI - 400001
BSE CODE: 530119 Sub: Submission of the Standalone Un-Audited Financial Results & Limited Review Report for the Quarter/Nine Months ended 31‘ December, 2020 u/r 33 of the SEBI (LODR) Regulations, 2015.
Dear Sir,
This is in continuation of our letter no. NPL/SE/2021 dated 28" January, 2021 regarding intimation of Board meeting for consideration and approval of the Quarterly/Nine Monthly Standalone Un-Audited Financial Results & Limited Review Report thereon, for the Quarter/Nine Months ended 31* December, 2020.
Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015 we are pleased to submit the following; (a) Standalone Unaudited Financial Results for the Quarter/Nine Months ended 31* December, 2020;
and
(b) Limited Review Report by the Auditors for the quarter ended 31% December, 2020,
Which was considered and approved by the Board at their 05/2020-21 Meeting held on Wednesday, the 10" February, 2021 at 3:00 P.M.
The Financial Results will also be published in widely circulated English and Hindi (Vernacular) newspaper in the prescribed format for that purpose.
We are also in process of filing the aforesaid financial results in the XBRL format within the stipulated time and same shall be hosted on the Website of the Company.
You are requested to please take on record the above said Standalone Unaudited financial results & Limited Review Report for your reference and record.
Thanking You, Yours Faithfully,“
For, NATRAF PROTEINS |
&
KAILASH CHAND We oad CHAIRMAN & MANAGING DIRECTOR DIN: 00012900 ~ Encl.: Standalone Unaudited Financial Results and Limited Review Report.
NATRAJ PROTEINS LIMITED CIN: L00153MP1990PLC006090
Regd. Off. -Nagpur Kalan, Ordinance Factory Road, Itarsi, (M.P.)-461111
Email: natrajproteinltd@rediffmail.com Website: www.natrajproteins.com
Statement of Standalone Unaudited Financial Statements for the Quarter/Nine Months
Ended on 31°t December, 2020
(Rupees in Lakhs except EPS)
S. Particulars Quarter Ended Nine Months Ended Year Ended
No. 31/12/2020 | 30/09/2020 | 31/12/2019 | 31/12/2020 | 31/12/2019 | 31/03/2020
Unaudited | Unaudited | Unaudited | Unaudited | Unaudited Audited
1 Revenue from Operations 4642.85 2918.15 6923.93 9943.77 11704.92 15412.86
Il__ | Other Income 1.95 2.00 0.18 5.46 3.43 4.60
Ill__| Total Income (I+ ID) 4644.80 2920.15 6924.11 9949.23 11708.35 15417.46
IV_| EXPENSES
a | Cost of materials consumed 5066.66 1913.36 5550.81 9502.87 9344.22 12150.19
b___| Purchases of Stock-in-Trade 39.45 246.27 260.59 469.88 1528.94 1734.22 |
c |Changes in inventories of finished (1069.09) 810.07 747.60 (602.53) 8.72 480.87
goods, Stock-in-Trade and
work-in-progress
d__| Employee benefits expense 29.86 28.52 33.68 87.46 96.89 132.23
e___| Finance costs 43.47 26.49 72.68 137.84 274.37 361.09
f |Depreciation and amortization 10.06 4.77 14.83 30.18 ATAT 63.17
expense
g___| Other expenses 266.4 70.93 184.74 415.96 341.41 463.28
Total expenses (IV) 4386.81 3100.41 6864.93 10041.66 11641.72 15385.05
Vv. |Profit/(loss) before exceptional 257.99 (180.26) 59.18 (92.43) 66.63 32.41
items, extraordinary items and tax
(UU LV)
V1_| Exceptional Items = : - - - -
VII_ | Profit/(loss) before extraordinary 257.99 (180.26) 59.18 (92.43) 66.63 32.41
items and tax (V-VI)
VIII | Extraordinary Items - - = - - -
IX __| Profit/(loss) before tax (VII-VIID) 257.99 (180.26) 59.18 (92.43) 66.63 32.41.
X | Tax expense:
(1) Current tax - - 12.19 - 172) 4.62
(2) Deferred tax : - - - (6.10)
XI |Profit (Loss) for the period from 257.99 (180.26) 46.99 |> (92.43) 52.91 33.89
continuing operations (IX-X)
XII |Profit/(loss) from discontinued - - - - - -
operations (before tax)
XIN |Tax expense of discontinued “ " a - - -
operations
XIV |Profit/(loss) from Discontinued - - - - - -
operations (after tax) (XU-XUD
XV_ | Net Profit/(loss) for the period 257.99 (180.26) 46.99 (92.43) 52.91 33.89
(XI+XIV) XVI | Other Comprehensive Income
A (i) Items that will not be reclassified (2.45) 1.47 0.83 1.80 1.42 (2.77)
to profit or loss
(ii) Income tax relating to items that - - (0.17) - (0.29) 0.43
will not be reclassified to profit or loss
B (A Items that will be reclassified to - - " = - -
profit or loss ~
(ii) Income tax relating to items that = - - x *
will be reclassified to profit or loss
XVII | Total Comprehensive Income for the 255.54 (178.79) 47.65 (90.63)
period (XV-XVI)
(Comprising Profit (Loss) and Other
Comprehensive Income _for the
period)
XVIII | Paid up Equity Share Capital (Face 374.70 374.70 374.70 374.70 374.70 374.70
Value Rs.10 per share) XIX | Reserves (excluding Revenue - - - - - 3188.97
Reserve) as shown in the audited
balance sheet of the previous year.
XX |Earnings per equity share (for
continuing operations) (1) Basic 6.89 (4.81) 1.25 (2.47) 1.41 0.90 (2) Diluted 6.89 (4.81) 1.25 (2.47) 1.41 0.90
XXI |Earnings per equity share (for
Discontinued operations)
(1) Basic - - - - = =
(2) Diluted - - _ ie 2 5
XXII |Earnings per equity share (for
continuing and Discontinued
operations) (1) Basic 6.89 (4.81) 1.25 (2.47) 1.41 0.90 (2) Diluted 6.89 (4.81) 1.25 (2.47) 1.41 0.90
Notes :- 1. These results have been prepared in accordance with the Indian Accounting Standard (referred to as "Ind AS") 34
Interim Financial Reporting prescribed under Section 133 of the Companies Act, 2013 read with Companies (Indian Accounting Standards) Rules as amended from time to time. These results have been reviewed by the
Audit Committee and approved by the Board of Directors at its meeting held on 10" February, 2021. The statutory
auditors have expressed an unmodified audit opinion on these results.
2. The company operates in two segments i.e. solvent extraction and commodities derivative trading. However, for
the current quarter as well as corresponding quarter in previous year there is no requirement of segmental
reporting as the sales of commodities/derivatives are less than the threshold limits.
3. Previous period figures have been regrouped/reclassified wherever necessary to confirm to this period
classification.
4. Asrequired under regulation 33 of SEBI (LODR) Regulation, 2015 the Limited Review by the Statutory Auditors
have been completed for the quarter and nine months ended on 31* December, 2020. The report does not have any
impact on the above results and notes which needs explanations.
5. COVID-19 has affected business operations of the Company with manufacturing, sales, supply chain, cash flows
etc. continuing to be impacted. The manufacturing facility of the Company which was shut down from 256
March, 2020 due to country wide lockdown, resumed operations in a phased manner from June, 2020 after
obtaining requisite approvals. Plants of the Company operated at below capacity during this quarter. The offices
and manufacturing units of the Company started operations in line with the Unlock advisory. The uncertainties
associated with the situation continue to evolve and the Company is monitoring them closely, The impact of
COVID-19 on the standalone financial results may differ from that estimated as at the date of approval of these
results. The Company will keep adjusting as called for from time to time to best cushion the adverse impact from
this scenario, if any.
6. The Indian Parliament has approved the Code on Social Security, 2020 which would impact the contributions by
the company towards Provident Fund and Gratuity. The effective date from which the changes are applicable is
yet to be notified and the rules for quantifying the financial impact are yet to be framed. Based on an initial
assessment by the Company and its Indian subsidiaries, the additional impact on Provident Fund contributions by
the Company is not expected to be material, whereas the likely additional impact on Gratuity
liability/contributions by the Company. The Company will complete their evaluation and will give appropriate
impact in the financial statements in the period in which, the Code becomes effective and the related rules to
determine the financial impact are published. Zé
7. Effective from 1‘ April, 2019, the company has adopted Indian Accounting Standard (IND-AS 116) “Leases”
Date: 10.02.2021
Place: Itarsi
using the “Modified Prospective Approach’’. The adoption of the said IND AS did not have any impact on the
retained earnings as at 1‘ April, 2020 and there was no material impact on financial results for the quarter/Nine
Months ended on 31%t December, 2020.
For, NATRAJ PROTER
KAILASH CH¢¥ . [
Chairman & Managi
DIN: 00012900
ANUP SHRIVASTAVA & ASSOCIATES
CHARTERED ACCOUNTANTS
Independent Auditor's Review Report on the Quarterly and Nine Monthly Unaudited
Standalone Financial Results of the Company . .
(Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, as amended.)
To,
The Board of Directors of
NATRAJ PROTEINS LIMITED
Itarsi (M.P.)
We have reviewed the accompanying statement of unaudited financial results of Natraj Proteins Limited for the period ended
December 31. 2020 and year to date from April 01, 2020 to December 31, 2020 (the Statement)attached herewith, being
submitted by the company pursuant to the requirement of regulation 33 of the SEB! (listing Obligation and Disclosure
Requirements) Regulation,2015, as amended. This statement is the responsibility of the Company’s Management and has
been approved by the Board of Directors. Our responsibility is to issue a report on these financial statements based on our
review.
We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 “Review
of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered
Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether
the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel
and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an
audit and accordingly, we do not express an audit opinion.
Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying
statement of unaudited financial results prepared in accordance with applicable accounting standards and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be
disclosed, or that it contains any material misstatement.
Emphasis Matter
The Company is not required to spend any fresh amount towards CSR for the period under review being the prescribed
limits applicable for CSR has not exceeded during the preceeding 3 financial years. Further that the company is carrying the
unspent amount of Rs.33.48 lakhs for the year 2014-15, 2015-16 and 2016-17. However the Company has expended Rs.6.12 lakhs towards the CSR activities from it . Thus the Company is now required to spend total amount of Rs.27.36 Lakhs.
The Company has considered the possible effects that may result from the pandemic relating to COVID-19 on the carrying amounts of receivables, unbilled revenues. In developing the assumptions relating to the possible future uncertainties in the economic conditions because of this pandemic, the Company, as at the date of approval of these financial statements has used internal and external sources of information including , subsequent payments received from debtors subsequent to the date of the financial statements. The Company based on current estimates expects the carrying amount of these assets will be recovered with extended credit period.
Our conclusion is not modified in respect of this matter.
For, Anup Shrivastava & Associates Chartered Accountants-~+. FERN No. 006455C
Place: Bhopal Seg
Date: 10.02.2021 0 -« Gene
pint 2a a aidueeae Prat romans CA Sudeep: Moitrey?! (Partner) ~~ @HOPNY-7 |
M. No. 400340—.
OFFICE : RAMA COMPLEX, 163, ZONE-I, S-1, IInd Floor, M.P. NAGAR, BHOPAL - 462011
Phone : (0) 2555642 (0), +91 9827016895 (M) E-mail smoitra.ca@gmail.com
Recommended